Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for severe disruptive behavior in children and adolescents with autism spectrum disorders
NL-OMON23170Active, not recruiting
- Sponsor
- Accare
- Start
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Autism Spectrum Disorder (ASD) comparing Continued risperidone with Placebo after risperidone phase (2 arms). Primary endpoints: Aberrant Behavior Checklist Irritability Scale, Clinician's Global Improvement score and 1 more. Started May 2002; status: active, not recruiting.
02
Drugs
risperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NL-OMON23170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23170.